ScopeSys

Successful applicants of the Women Entrepreneurship and the president of ScopeSys, Dr. Sabrina Leslie is also among them! #womenentrepreneurship https://lnkd.in/gpUz-Rc

https://lnkd.in/eXbqm83j

🌟Reflecting on 2023: A Year of Milestones at ScopeSys🌟 As we dive into the new year, let's take a moment to celebrate the remarkable achievements of 2023 and extend our heartfelt gratitude to all our collaborators in the nanomedicine space. Your dedication and partnership continue to propel us forward. 🏆 #ScopeSys has been recognized as a "Company to Watch" by Life Sciences BC in its 25th anniversary edition. Sharing this accolade with esteemed peers like #BoldTherapeuticsInc.,#GandeevaTherapeutics, and #SonicIncytesMedicalCorp. underscores the impactful strides we've made as an early-stage company. This recognition inspires us to push boundaries and innovate even further. 💡 Securing a coveted spot at the #SBME Innovates incubator within UBC's Biomedical Research Center marks a significant milestone in our journey. This incubator is a hub for biotech innovation, providing invaluable resources to accelerate our growth and amplify our impact. We're eager to leverage this opportunity as we continue to scale up and drive positive change in the industry. 🔬 Exciting news on the research front! Our CLiC microscopy imaging system has been prominently featured in a recent publication co-authored with #LeslieLab and #CullisLab. Titled "Determination of the interior pH of lipid nanoparticles using a pH-sensitive fluorescent dye-based DNA probe," this study showcases the cutting-edge capabilities of our technology. Dive into the details of our groundbreaking research: https://lnkd.in/d5QN_zn9. Together, these achievements epitomize our commitment to advancing nanomedicine and revolutionizing healthcare. As we embark on the journey ahead, let's carry forward the spirit of collaboration, innovation, and excellence that defines ScopeSys.

ScopeSys was delighted to be a part of the NMIN 2024 Research Conference held in Vancouver this past week. 🌟 This dynamic gathering brought together an exceptional assembly of scientific leaders, researchers, trainees, as well as representatives from industry and non-profit organizations, embodying the vibrant Canadian Nanomedicines ecosystem. The event provided an excellent platform to engage with participants, fostering discussions on the latest breakthroughs, emerging trends, and key priorities within the Nanomedicines landscape. Connecting with like-minded professionals not only enriched our understanding but also fueled our commitment to driving advancements ni this transformative field. 🚀 #NMIN #NMIN2024conference #ScopeSys #Nanomedicine #NanomedicinesinCanada

🏆 Honoring Excellence in Medical Innovation 🌟   ScopeSys is thrilled to join the global nanomedicine community in celebrating the remarkable achievement of Dr. Katalin Karikó and Dr. Drew Weissman, who have been awarded the 2023 Nobel Prize in Physiology or Medicine for their groundbreaking work on "Discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19."   Their pioneering research has had a profound impact on the world, paving the way for the rapid approval of two mRNA-based COVID-19 vaccines in late 2020. Dr. Karikó and Dr. Weissman's work has shown that mRNA, when produced with modified bases, can effectively evade innate immune recognition and enhance protein expression. This pivotal discovery has been instrumental in overcoming the challenges of inflammatory responses and inefficient protein production associated with in vitro transcribed mRNA in cells and tissues.   We extend our heartfelt congratulations to Dr. Karikó and Dr. Weissman for their extraordinary contribution to the field of medicine. Their dedication and innovation have not only saved countless lives but also inspired a new era of mRNA-based therapeutics.    For more details, please read the official press release: https://bit.ly/3LyuMgU   #NobelPrize #MedicalInnovation #COVID19Vaccines #Nanomedicine #Inspiration

https://lnkd.in/e9diC4hB 🌟 Exciting News! ScopeSys is thrilled to announce that we have been selected as one of the "Companies to Watch" by Life Sciences BC in 2023.  We are honored to receive this recognition, which highlights our commitment to shaping the future of healthcare in Canada through relentless innovation and unwavering dedication.  At ScopeSys, we've pioneered a groundbreaking single-molecule imaging platform with the power to revolutionize the field of genomic medicine. Our platform offers novel analysis capabilities, propelling advancements in the development of RNA, DNA, and nanoparticle-delivered drugs. Explore the endless possibilities that our technology unlocks for the healthcare industry. Visit our website at www.scopesys.ca to learn more about how we are making a difference.  Join us in celebrating this milestone as we continue to push the boundaries of innovation in healthcare! 🎉 #LSBC #Innovation #SingleMoleculeImaging #HealthcareInnovation #GenomicMedicine #LifeSciencesBC

https://lnkd.in/eujWUnn7 Congratulations to Dr. Peter Zandstra on winning the inaugural Scientific Entrepreneurship Award from Life Sciences BC. This award is a testament to Dr. Zandstra's outstanding contributions to the field of biomedical engineering and entrepreneurship. His entrepreneurship is an inspiration to a new generation of professionals. We celebrate Dr. Peter Zandstra's remarkable achievements and the bright future he continues to shape for the next generation of scientific leaders. To learn more about his brilliant career , check out https://lnkd.in/ghaFv2_5 #LSBCawards #ScientificEntrepreneurship #Innovation #Inspiration